The latest Investing Matters Podcast episode featuring Jeremy Skillington, CEO of Poolbeg Pharma has just been released. Listen here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksCNKS.L Regulatory News (CNKS)

  • There is currently no data for CNKS

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Form 8.5 (EPT/NON-RI)

14 Aug 2017 09:40

RNS Number : 8961N
Cenkos Securities PLC
14 August 2017
 

FORM 8.5 (EPT/NON-RI)

 

PUBLIC OPENING POSITION DISCLOSURE/DEALING DISCLOSURE BY AN

EXEMPT PRINCIPAL TRADER WITHOUT RECOGNISED INTERMEDIARY ("RI") STATUS (OR WHERE RI STATUS IS NOT APPLICABLE)

Rule 8.5 of the Takeover Code (the "Code")

 

1. KEY INFORMATION

 

(a) Name of exempt principal trader:

Cenkos Securities plc

(b) Name of offeror/offeree in relation to whose relevant securities this form relates:

Use a separate form for each offeror/offeree

Aberdeen Asset Management plc

(c) Name of the party to the offer with which exempt principal trader is connected:

Aberdeen Asset Management plc

(d) Date position held/dealing undertaken:

11/08/2017

(e) In addition to the company in 1(b) above, is the exempt principal trader making disclosures in respect of any other party to the offer?

No

 

2. POSITIONS OF THE EXEMPT PRINCIPAL TRADER

 

 

(a) Interests and short positions in the relevant securities of the offeror or offeree to which the disclosure relates following the dealing (if any)

 

Class of relevant security:

 

10p ordinary

 

 

Interests

Short positions

Number

%

Number

%

(1) Relevant securities owned and/or controlled:

7,500

0.001

(2) Cash-settled derivatives:

 

(3) Stock-settled derivatives (including options) and agreements to purchase/sell:

 

TOTAL:

7,500

0.001

 

 

 

(b) Rights to subscribe for new securities (including directors' and other employee options)

 

Class of relevant security in relation to which subscription right exists:

Details, including nature of the rights concerned and relevant percentages:

 

 

3. DEALINGS (IF ANY) BY THE EXEMPT PRINCIPAL TRADER

 

Where there have been dealings in more than one class of relevant securities of the offeror or offeree named in 1(b), copy table 3(a), (b), (c) or (d) (as appropriate) for each additional class of relevant security dealt in.

 

The currency of all prices and other monetary amounts should be stated.

 

(a) Purchases and sales

 

Class of relevant security

Purchases/ sales

 

Total number of securities

Highest price per unit paid/received

Lowest price per unit paid/received

10p ordinary

Purchases

20,524

318p

312.8p

10p ordinary

Sales

13,024

317.8p

316.1p

 

 

(b) Cash-settled derivative transactions

 

Class of relevant security

Product description

e.g. CFD

Nature of dealing

e.g. opening/closing a long/short position, increasing/reducing a long/short position

Number of reference securities

Price per unit

 

 

 

(c) Stock-settled derivative transactions (including options)

 

(i) Writing, selling, purchasing or varying

 

Class of relevant security

Product description e.g. call option

Writing, purchasing, selling, varying etc.

Number of securities to which option relates

Exercise price per unit

Type

e.g. American, European etc.

Expiry date

Option money paid/ received per unit

 

(ii) Exercise

 

Class of relevant security

Product description

e.g. call option

Exercising/ exercised against

Number of securities

Exercise price per unit

 

 

 

(d) Other dealings (including subscribing for new securities)

 

Class of relevant security

Nature of dealing

e.g. subscription, conversion

Details

Price per unit (if applicable)

 

 

 

 

4. OTHER INFORMATION

 

(a) Indemnity and other dealing arrangements

 

Details of any indemnity or option arrangement, or any agreement or understanding, formal or informal, relating to relevant securities which may be an inducement to deal or refrain from dealing entered into by the exempt principal trader making the disclosure and any party to the offer or any person acting in concert with a party to the offer:

 

none

 

 

 

(b) Agreements, arrangements or understandings relating to options or derivatives

 

Details of any agreement, arrangement or understanding, formal or informal, between the exempt principal trader making the disclosure and any other person relating to:

(i) the voting rights of any relevant securities under any option; or

(ii) the voting rights or future acquisition or disposal of any relevant securities to which any derivative is referenced:

 

none

 

 

 

(c) Attachments

 

Is a Supplemental Form 8 (Open Positions) attached?

NO

 

 

Date of disclosure:

14/08/2017

Contact name:

Parin Hirani

Telephone number:

020 7397 8985

 

Public disclosures under Rule 8 of the Code must be made to a Regulatory Information Service and must also be emailed to the Takeover Panel at monitoring@disclosure.org.uk. The Panel's Market Surveillance Unit is available for consultation in relation to the Code's disclosure requirements on +44 (0)20 7638 0129.

 

The Code can be viewed on the Panel's website at www.thetakeoverpanel.org.uk.

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
FEOGGURWRUPMURC
Date   Source Headline
4th Apr 20234:35 pmRNSForm 8.3-Sarah Keys & Stephen Keys-Cenkos-Amended
4th Apr 20232:47 pmRNSForm 8.3 - Cenkos Securities
4th Apr 202311:30 amRNSForm 8.3 - Cenkos Securities plc
4th Apr 202310:17 amRNSForm 8.5 (EPT/NON-RI) - US Solar Fund PLC
4th Apr 202310:05 amRNSForm 8.5 (EPT/NON-RI)
3rd Apr 20233:21 pmRNSForm 8.3(OPD) - N Wells & M-L Wells - Cenkos
3rd Apr 20239:06 amRNSForm 8.5 (EPT/NON-RI)
31st Mar 20236:39 pmRNSForm 8.3 (OPD) Jim Durkin - Cenkos - Amended
31st Mar 20236:23 pmRNSForm 8.3 (OPD) Peter Isard & Nicola Isard - Cenkos
31st Mar 20236:12 pmRNSForm 8.3 - (OPD) Zedra Trust Company - Cenkos
31st Mar 20236:07 pmRNSForm 8.3 - (OPD) Apex Financial Services - Cenkos
31st Mar 20235:42 pmRNSForm 8.3 - (OPD) Cenkos Securities plc
31st Mar 20235:42 pmRNSForm 8.3 - (OPD) Cenkos Securities Plc
31st Mar 20235:23 pmRNSForm 8 (OPD) (Cenkos Securities Plc)
31st Mar 20238:55 amRNSForm 8.5 (EPT/NON-RI) - US Solar Fund PLC
30th Mar 202310:59 amRNSForm 8.5 (EPT/NON-RI)
29th Mar 20235:21 pmRNSForm 8.3 - CENKOS SECURITIES PLC
29th Mar 20238:46 amRNSForm 8.3 (OPD) Sarah Keys - Cenkos Securities plc
29th Mar 20238:39 amRNSForm 8.5 (EPT/NON-RI)
28th Mar 20231:24 pmRNSForm 8.3 (OPD) Jim Durkin - Cenkos Securities plc
27th Mar 20238:58 amRNSForm 8.5 (EPT/NON-RI)
24th Mar 20232:13 pmRNSForm 8.3 - Cenkos Securities PLC
24th Mar 20231:23 pmGNWForm 8.3 - [Cenkos Securities plc - Opening Declaration - 23 03 2023] - (CGAML)
24th Mar 202310:58 amRNSFurther re Directorate Change
24th Mar 20238:40 amRNSForm 8.5 (EPT/NON-RI)
23rd Mar 20237:01 amRNSRecommended All-Share Merger with finnCap
23rd Mar 20237:00 amRNSRecommended All-Share Merger with Cenkos
21st Mar 202310:40 amRNSForm 8.5 (EPT/NON-RI)
20th Mar 20238:56 amRNSForm 8.5 (EPT/NON-RI)
20th Mar 20237:00 amRNSPosting of Annual Report and AGM Notice
16th Mar 20238:45 amRNSForm 8.5 (EPT/NON-RI)
10th Mar 202312:55 pmRNSDividend Record and Payment Dates
10th Mar 202310:10 amRNSForm 8.5 (EPT/NON-RI)
10th Mar 20237:00 amRNSAnnual Results for the year ended 31 December 2022
9th Mar 20238:48 amRNSForm 8.5 (EPT/NON-RI)
2nd Mar 20239:09 amRNSForm 8.5 (EPT/NON-RI)
1st Mar 202310:12 amRNSForm 8.5 (EPT/NON-RI)
28th Feb 20239:29 amRNSForm 8.5 (EPT/NON-RI)
27th Feb 20238:39 amRNSForm 8.5 (EPT/NON-RI) - US Solar Fund PLC
24th Feb 20239:09 amRNSForm 8.5 (EPT/NON-RI)
17th Feb 202310:42 amRNSForm 8.5 (EPT/NON-RI)
16th Feb 20238:17 amRNSForm 8.5 (EPT/NON-RI)
14th Feb 20238:47 amRNSForm 8.5 (EPT/NON-RI)
13th Feb 20239:05 amRNSForm 8.5 (EPT/NON-RI)
10th Feb 20238:33 amRNSForm 8.5 (EPT/NON-RI)
9th Feb 202310:15 amRNSForm 8.5 (EPT/NON-RI)
8th Feb 20239:16 amRNSForm 8.5 (EPT/NON-RI)
8th Feb 20237:00 amRNSTrading Update
7th Feb 20238:32 amRNSForm 8.5 (EPT/NON-RI)
6th Feb 20239:24 amRNSForm 8.5 (EPT/NON-RI)

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.